The Alzheimer's Drug Discovery Foundation (ADDF) is a U.S.-based nonprofit organization that accelerates the discovery and development of drugs, diagnostics, and therapies to prevent, treat, and cure Alzheimer’s disease, other dementias, and age‑related cognitive decline. Using a venture‑philanthropy model, ADDF funds breakthrough research in academia and biotech, runs funding programs, diagnostic accelerators, and prize initiatives, and provides resources for patients, families, and the scientific community.
No recent news for this company.